Drospirenone And Ethinyl Estradiol Kit
Product Images NDC 68180-868

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Drospirenone And Ethinyl Estradiol (NDC 68180-868). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (6807fca4 5086 43a9 A7e7 Ac6e61b64be4 01)

A forest plot showing hazard ratios, rate ratios, and odds ratios from various studies including Ingeinix, EURAS, LASS, FDA-funded, Danish, MEGA, German case-control, PharMetrics, and GPRD studies. The chart categorizes studies into prospective cohort, retrospective cohort, case-control, and non-fetal idiopathic cases, illustrating relative risk measures with confidence intervals around a reference value of 1 on a logarithmic scale.*

FDA Label Image

Figure 2 (6807fca4 5086 43a9 A7e7 Ac6e61b64be4 02)

A horizontal bar chart depicting the number of women with a blood clot per 10,000 woman years (WY) across four categories: Non-Pregnant Non-COC user (1-5 range), COC-User (3-9 range), Pregnancy (5-20 range), and Postpartum (12 weeks only) with the highest range (40-65). The chart includes a note indicating pregnancy data is based on the actual duration in reference studies and assumes a nine-month pregnancy duration for rate calculation.*

FDA Label Image

Structure Formula (6807fca4 5086 43a9 A7e7 Ac6e61b64be4 03)

Chemical structure diagram showing the molecular formulas of Drospirenone and Ethinyl estradiol, the active ingredients in the product. Drospirenone's structure is displayed on the left, and Ethinyl estradiol's structure is on the right.*

FDA Label Image

Image (6807fca4 5086 43a9 A7e7 Ac6e61b64be4 04)

An effectiveness chart illustrating methods of contraception and their relative pregnancy rates per 100 women in one year. The vertical arrow shows decreasing pregnancies from bottom to top, listing no birth control at the bottom (85 or more pregnancies), followed by no sex during fertile days, spermicide, and withdrawal; condoms and diaphragm; birth control pills, skin patch, vaginal ring; and implants, injections, intrauterine devices, and sterilization at the top (fewer than 1 pregnancy).*

FDA Label Image

Image (6807fca4 5086 43a9 A7e7 Ac6e61b64be4 05)

An instructional diagram showing a 28-day oral contraceptive pill regimen. The diagram is organized in four rows labeled Week 1 to Week 4, each containing seven circular pill slots labeled with days of the week (Sunday to Saturday). Arrows indicate the sequence for taking the pills, starting from Week 1 Sunday and progressing through the four weeks. The diagram also includes a note to perform a monthly self breast exam.*

FDA Label Image

Figure (6807fca4 5086 43a9 A7e7 Ac6e61b64be4 06)

A horizontal bar graph depicting the number of women with a blood clot per 10,000 women years (WY) across four groups: Non-Pregnant Non-COC users (1 to 5), COC-Users (3 to 9), Pregnancy (5 to 20), and Postpartum (12 weeks only) with the highest range from 40 to 65. A note explains pregnancy data is based on nine months duration with a rate of 7 to 27 per 10,000 WY.*

FDA Label Image

Wallet, Carton (6807fca4 5086 43a9 A7e7 Ac6e61b64be4 07)

DROSPIRENONE AND ETHINYL ESTRADIOL kit packaging label shows tablets with 3 mg drospirenone and 0.03 mg ethinyl estradiol strength. The label includes dosing schedule circles for a 28-day regimen organized by day of the week and week number, with instructions to start on Sunday. The label also lists storage conditions, distributor Lupin Pharmaceuticals, Inc., and manufacturer Lupin Limited information along with lot and expiration placeholders.*

FDA Label Image

Pouch (6807fca4 5086 43a9 A7e7 Ac6e61b64be4 08)

Box label for Drospirenone and Ethinyl Estradiol Tablets USP, 3 mg/0.03 mg, in a kit form. The packaging is red and white with text indicating the product is Rx only and contains 1 blister of 28 tablets. The labeler is Lupin Pharmaceuticals, Inc. The NDC number 68180-868 is visible along with barcode images and usage information.*

FDA Label Image

Carton (6807fca4 5086 43a9 A7e7 Ac6e61b64be4 09)

Packaging label for Drospirenone and Ethinyl Estradiol Tablets USP, 3 mg/0.03 mg, in a kit form by Lupin Pharmaceuticals, Inc. The label indicates 3 blisters of 28 tablets each. It includes dispensing and usage information, warnings, and manufacturer details, along with barcodes and the NDC 68180-868-73.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.